User:Cecilia Cisar/Notebook/Mod 3 Research Proposal: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
* During certain stages of growth, cancer cells exhibit unique miRNA signatures.<ref>Calin, George A., and Carlo M. Croce. "MicroRNA signatures in human cancers." Nature Reviews Cancer 6.11 (2006): 857-866.</ref>
* During certain stages of growth, cancer cells exhibit unique miRNA signatures.<sup>[1]</sup>


* Some organisms use miRNA to target and inhibit sections of bacterial DNA.<ref>Ma, Feng, et al. "The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]."Nature immunology 12.9 (2011): 861-869.</ref>
* Some organisms use miRNA to target and inhibit sections of bacterial DNA.<sup>[2]</sup>


==References==
==References==
<references />
* Calin, George A., and Carlo M. Croce. "MicroRNA signatures in human cancers." Nature Reviews Cancer 6.11 (2006): 857-866.
*Ma, Feng, et al. "The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]."Nature immunology 12.9 (2011): 861-869.


|-
|-

Revision as of 15:15, 5 May 2014

Project Description/Abstract

  • To design bacteria that use specific miRNA signatures to target cancer cells.

Overview

  • During certain stages of growth, cancer cells exhibit unique miRNA signatures.[1]
  • Some organisms use miRNA to target and inhibit sections of bacterial DNA.[2]

References

  • Calin, George A., and Carlo M. Croce. "MicroRNA signatures in human cancers." Nature Reviews Cancer 6.11 (2006): 857-866.
  • Ma, Feng, et al. "The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]."Nature immunology 12.9 (2011): 861-869.
Recently Edited Notebook Pages